抗凝治疗的原则与实践。
The principles and practice of anticoagulant therapy.
作者信息
Carter C J
出版信息
Can Fam Physician. 1987 Nov;33:2557-60.
Abstract
The author describes the clinical rationale and pharmacology of current anticoagulant therapy. He goes on to discuss the intensity of therapy by means of oral anticoagulants, the means of monitoring this therapy, and the standardization of monitoring procedures. He also describes the indications for and best means of administering and monitoring heparin therapy, together with the major clinical indications for both heparin and oral anticoagulant therapy.
摘要
作者描述了当前抗凝治疗的临床基本原理和药理学。他接着讨论了通过口服抗凝剂进行治疗的强度、监测该治疗的方法以及监测程序的标准化。他还描述了肝素治疗的适应证、给药和监测的最佳方法，以及肝素和口服抗凝剂治疗的主要临床适应证。
相似文献
1
The principles and practice of anticoagulant therapy.抗凝治疗的原则与实践。
Can Fam Physician. 1987 Nov;33:2557-60.
2
3
[-Anticoagulant drugs-].[-抗凝血药物-]
Herz. 1996 Feb;21(1):12-27.
4
A single center retrospective cohort study comparing low-molecular-weight heparins to direct oral anticoagulants for the treatment of venous thromboembolism in patients with cancer - A real world experience.一项单中心回顾性队列研究：比较低分子肝素与直接口服抗凝剂治疗癌症患者静脉血栓栓塞症——真实世界经验
J Oncol Pharm Pract. 2019 Jun;25(4):793-800. doi: 10.1177/1078155218757856. Epub 2018 Feb 20.
5
Hemorrhagic complications of anticoagulant treatment.抗凝治疗的出血并发症
Chest. 2001 Jan;119(1 Suppl):108S-121S. doi: 10.1378/chest.119.1_suppl.108s.
6
Anticoagulants for venous thrombosis.用于静脉血栓形成的抗凝剂。
Postgrad Med J. 1997 May;73(859):283-5. doi: 10.1136/pgmj.73.859.283.
7
8
Updates on Anticoagulation and Laboratory Tools for Therapy Monitoring of Heparin, Vitamin K Antagonists and Direct Oral Anticoagulants.肝素、维生素K拮抗剂及直接口服抗凝剂抗凝治疗进展与实验室监测工具
Biomedicines. 2021 Mar 7;9(3):264. doi: 10.3390/biomedicines9030264.
9
Anticoagulant therapy in patients undergoing dental interventions: a critical review of the literature and current perspectives.牙科干预患者的抗凝治疗：文献综述与当前观点
Minerva Stomatol. 2015 Feb;64(1):21-46.
10
[A case of heparin-induced thrombocytopenia after transurethral resection of prostate during anticoagulant therapy].[抗凝治疗期间经尿道前列腺切除术后发生肝素诱导的血小板减少症1例]
Nihon Hinyokika Gakkai Zasshi. 2001 Nov;92(7):702-5. doi: 10.5980/jpnjurol1989.92.702.
本文引用的文献
1
Prevention of venous thromboembolism after total knee replacement by high-dose aspirin or intermittent calf and thigh compression.高剂量阿司匹林或间歇性小腿及大腿加压预防全膝关节置换术后静脉血栓栓塞
Br Med J. 1980 Feb 23;280(6213):514-7. doi: 10.1136/bmj.280.6213.514.
2
Bleeding during acetylsalicylic acid and anticoagulant therapy in patients with reduced platelet reactivity after aortic valve replacement.主动脉瓣置换术后血小板反应性降低的患者在接受乙酰水杨酸和抗凝治疗期间的出血情况。
Am Heart J. 1980 Jun;99(6):746-52. doi: 10.1016/0002-8703(80)90625-0.
3
Intensity of oral anticoagulation in patients monitored with various thromboplastins.使用不同凝血活酶监测的患者口服抗凝强度
N Engl J Med. 1983 May 19;308(20):1228-9. doi: 10.1056/NEJM198305193082015.
4
Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.不同强度的口服抗凝治疗在近端静脉血栓形成治疗中的应用
N Engl J Med. 1982 Dec 30;307(27):1676-81. doi: 10.1056/NEJM198212303072704.
5
Anticoagulant action of heparin.肝素的抗凝作用。
Nature. 1973 Dec 7;246(5432):355-7. doi: 10.1038/246355a0.
6
7
Thromboplastin and oral anticoagulant control.凝血活酶与口服抗凝剂控制
Br J Haematol. 1987 May;66(1):1-4.
8
A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery.一项关于低分子量肝素（依诺肝素）预防择期髋关节手术患者深静脉血栓形成的随机对照试验。
N Engl J Med. 1986 Oct 9;315(15):925-9. doi: 10.1056/NEJM198610093151503.
9
Hemorrhagic complications of anticoagulant therapy.抗凝治疗的出血并发症。
Semin Thromb Hemost. 1986 Jan;12(1):39-57. doi: 10.1055/s-2007-1003533.
10
Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism.在亚大面积静脉血栓形成或肺栓塞后早期开始使用华法林的安全性和有效性。
Lancet. 1986 Dec 6;2(8519):1293-6. doi: 10.1016/s0140-6736(86)91431-5.
Zotero 插件